💊
Drug Delivery
Novel delivery platforms including lipid nanoparticles, antibody-drug conjugates, and sustained-release formulations.
Companies
0
Pipeline Drugs
10
Key People
16
Drug Delivery Pipeline (10 drugs)
Approved: 5Device Development: 2Approved (CE Mark): 1Investigational: 1Commercial: 1
| Drug | Company | Indication | Phase |
|---|---|---|---|
| HYLENEX® recombinant | Halozyme Therapeutics | Hypodermoclysis and subcutaneous fluid administration | Approved |
| XYOSTED® CIII | Halozyme Therapeutics | Testosterone replacement therapy | Approved |
| CytoSorb® / CytoSorb 300® | CytoSorbents | Reduction of elevated cytokines, bilirubin, myoglobin; Removal of Ticagrelor/Rivaroxaban during cardio-pulmonary bypass surgery | Approved (CE Mark) |
| DrugSorb-ATR® | CytoSorbents | Removal of Ticagrelor and Rivaroxaban (antiplatelet/anticoagulant drugs) in cardiothoracic surgery | Investigational |
| PuriFi | CytoSorbents | Hemoperfusion system to enable independent CytoSorb® therapy | Device Development |
| ECOS-300CY | CytoSorbents | Use with Ex Vivo Organ Perfusion (EVOP) to manage inflammatory processes in donor organs | Device Development |
| VetResQ | CytoSorbents | Veterinary critical-care applications | Commercial |
| ABC Syringe Infusion Pump Model 4100 (Enteral) | Atlanta Biomedical | Delivery of enteral feeds / nutrition | Approved |
| ABC Syringe Infusion Pump Model 4100 (IV) | Atlanta Biomedical | Intravenous medication delivery | Approved |
| ABC RPC 001-5990 Rotating Pole Clamp | Atlanta Biomedical | Medical device accessory for pump mounting | Approved |
Key People in Drug Delivery
HT
Helen Torley
President and Chief Executive Officer
Halozyme Therapeutics
NL
Nicole LaBrosse
Chief Financial Officer
Halozyme Therapeutics
MS
Mark Snyder
Chief Legal Officer
Halozyme Therapeutics
CC
Chase Coffman
President of Hypercon™
Halozyme Therapeutics
PP
Phillip P. Chan, MD, PhD
Chief Executive Officer
CytoSorbents
EN
Efthymios N. Deliargyris, MD, FACC, FESC, FSCAI
Chief Medical Officer
CytoSorbents
PJ
Peter J. Mariani
Chief Financial Officer
CytoSorbents
DW
Daniel Wendt, FECTS, FACS, MHBA
Vice President Medical Cardio-Vascular
CytoSorbents
DJ
Dr. Jörg Scheier
Vice President Medical Critical Care
CytoSorbents
HA
Harriet Adamson
Senior Manager Medical Information
CytoSorbents
MB
Michael Bator
Chairman of the Board
CytoSorbents
ER
Edward R. Jones MD, MBA
Board of Directors, Clinical Professor of Medicine, Temple University Hospital
CytoSorbents
AD
Alan D. Sobel MS, CPA
Board of Directors, Managing Member, Sobel & Co., LLC
CytoSorbents
W(
William (Bill) Arthur III
Co-Founder
Atlanta Biomedical
CL
Charles Lee
Co-Founder, former senior R&D executive at MedFusion
Atlanta Biomedical